CVRx (CVRX) Shares Outstanding (Diluted Average) (2021 - 2026)
CVRx (CVRX) recorded quarterly Shares Outstanding (Diluted Average) of $26.4 million in Q1 2026, up 1.04% quarter-over-quarter from $26.1 million in Q4 2025, and up 1.85% on a YoY basis from $25.9 million in Q1 2025.
CVRx (CVRX) Shares Outstanding (Diluted Average) (2021 - 2026) Analysis & Trends
CVRx's Shares Outstanding (Diluted Average) history runs 6 years deep, the most recent figure standing at $26.4 million for Q1 2026.
- In Q1 2026, Shares Outstanding (Diluted Average) rose 1.85% year-over-year to $26.4 million; the TTM figure through Mar 2026 stood at $26.4 million (up 1.85% YoY), while the FY2025 annual figure was $26.1 million, up 15.44% from the prior year.
- Shares Outstanding (Diluted Average) was $26.4 million for Q1 2026 at CVRx, up from $26.1 million in the prior quarter.
- In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $26.4 million in Q1 2026 to a low of $20.5 million in Q1 2022.
- Historically, Shares Outstanding (Diluted Average) has averaged $22.5 million across 5 years, with a median of $21.2 million in 2024.
- The sharpest annual moves came in 2022 and 2023: Shares Outstanding (Diluted Average) surged 5570.85% in 2022, then grew 1.01% in 2023.
- A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $20.5 million in 2022, then gained by 1.08% to $20.8 million in 2023, then rose by 8.87% to $22.6 million in 2024, then rose by 15.44% to $26.1 million in 2025, then grew by 1.04% to $26.4 million in 2026.
- The last three Shares Outstanding (Diluted Average) figures came in at $26.4 million (Q1 2026), $26.1 million (Q4 2025), and $26.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Diluted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 1.75 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 386.50 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 1.29 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 1.50 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 580.70 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 393.60 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 457.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | - |
| 10 | CVRx | 130.46 Mn | 58.16 Mn | 12.88 Mn | 26.36 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 26.36 Mn |
| Dec 31, 2025 | 26.08 Mn |
| Sep 30, 2025 | 26.04 Mn |
| Jun 30, 2025 | 25.97 Mn |
| Mar 31, 2025 | 25.88 Mn |
| Dec 31, 2024 | 22.60 Mn |
| Sep 30, 2024 | 21.88 Mn |
| Jun 30, 2024 | 21.43 Mn |
| Mar 31, 2024 | 21.23 Mn |
| Dec 31, 2023 | 20.75 Mn |
| Sep 30, 2023 | 20.80 Mn |
| Jun 30, 2023 | 20.71 Mn |
| Mar 31, 2023 | 20.69 Mn |
| Dec 31, 2022 | 20.53 Mn |
| Sep 30, 2022 | 20.58 Mn |
| Jun 30, 2022 | 20.51 Mn |
| Mar 31, 2022 | 20.45 Mn |
| Dec 31, 2021 | 10.36 Mn |
| Sep 30, 2021 | 20.13 Mn |
| Jun 30, 2021 | 366,066.00 |